#glp-1 drugs
14 stories
GLP-1 drugs show anti-aging effects but side effects remain unclear
Weight-loss drugs reduce biological age markers, but researchers are still discovering unexpected effects on hair, nails, vision and more.
MIT Technology Review · 2m
AI's refusal problem and weight-loss drug side effects
Today's AI models are trained to refuse harmful requests, but those refusals sometimes fail catastrophically. Meanwhile, weight-loss drugs show unexpected side effects beyond their intended use.
MIT Technology Review · 2m
The risky boom in cut-price weight-loss drugs
Compounding pharmacies are flooding the market with cheaper versions of GLP-1 drugs, but with far less oversight than brand-name alternatives.
TIME · 3m
GLP-1 lawsuits mount as serious harms remain unclear
Thousands of patients are suing GLP-1 drugmakers over blindness and pancreatitis, but weak reporting systems make it hard to know how often the drugs cause real harm.
NPR · 2m
Push for subsidised weight-loss drugs for PMOS
Australian advocates want GLP-1 medications funded on the PBS for women with polyendrocrine metabolic ovarian syndrome, but approval remains uncertain.
the Guardian · 1m
Telehealth Companies Leak Medical Data
Telehealth firms share health data without permission, risking user privacy.
Seattletimes · 1m
McDonald's stock falls on big spending plan
McDonald's shares dropped 6% as the chain unveiled billions in restaurant upgrades and a new growth strategy at its investor day.
CNBC · 3m
New weight-loss drugs promise fewer side effects
Amylin-based medications show promise as alternatives to GLP-1 drugs, causing less nausea and stomach trouble while delivering comparable weight loss.
TIME · 2m
Lilly captures 70% of new Medicare GLP-1 patients
Eli Lilly CEO says 700,000 seniors started weight loss drugs after Medicare coverage launched in July, with Lilly drugs taking the majority.
CNBC · 1m
Lilly claims one-third of new GLP-1 pill patients
Eli Lilly CEO says Foundayo is capturing a third of new oral GLP-1 patients as the company breaks ground on a six point five billion dollar Houston manufacturing facility.
CNBC · 1m
Alzheimer's research is finally making real progress
After decades of stalled research, scientists now have new drugs and multiple treatment approaches that offer hope for slowing cognitive decline.
Vox · 3m
GLP-1 weight-loss drugs: what to know first
Experts break down the science, side effects, and safety questions before starting these popular metabolic medications.
Valleynewslive · 1m
Tropical Smoothie Cafe plans 3,000 new locations with fresh look
The fast-growing chain unveils new branding as it prepares for massive expansion under Blackstone ownership.
CNBC · 1m
Fasting on GLP-1 drugs: What you need to know for Yom Kippur
Millions take Ozempic and similar medications, adding a medical twist to religious fasts that require careful planning.
The Conversation · 2m